Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 9/20 | 0.55 |
| ▸ | AGTR2 | P50052 | 8/20 | 0.55 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7657851 | 0.93 | AGTR1 (0.59) | AGTR1AGTR2PPARGACHE | |
| SCHEMBL7659476 | 0.90 | AGTR1 (0.55) | AGTR1AGTR2PPARGACHE | |
| SCHEMBL7650695 | 0.90 | AGTR1 (0.55) | AGTR1AGTR2PPARGACHE | |
| SCHEMBL7653378 | 0.85 | AGTR1 (0.63) | AGTR1AGTR2PPARGACHE | |
| SCHEMBL7651413 | 0.84 | AGTR1 (0.53) | AGTR1AGTR2PPARGACHEADORA3 | |
| SCHEMBL7654063 | 0.84 | AGTR1 (0.54) | AGTR1AGTR2PPARGACHE | |
| SCHEMBL7650733 | 0.81 | AGTR1 (0.58) | AGTR1AGTR2PPARGACHE | |
| SCHEMBL7659945 | 0.80 | AGTR1 (0.55) | AGTR1AGTR2PPARGACHE | |
| SCHEMBL13277425 | 0.78 | PPARG (0.55) | AGTR1AGTR2PPARG | |
| SCHEMBL7661202 | 0.78 | PPARG (0.62) | AGTR1AGTR2PPARGACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6358984-B1 | FOR THERAPY OF HYPERTENSION AND/OR DISEASES SUCH AS HEART AND RENAL DISEASES | LEAD CHEMICAL CO., LTD. (JP) | 2002-03-19 | — | — | US | disclosed |
| US-6232335-B1 | A BIPHENYL TRIAZOLE COMPOUND USEFUL AS A ANGIOTENSIN II CONVERTING ENZYME INHIBITORS EFFECTIVE IN THE TREATMENT OF HYPERTENSION OR HEART FAILURE | LEAD CHEMICAL CO., LTD. (JP) | 2001-05-15 | — | — | US | disclosed |